The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.

• Main Authors: Myra Hardy (Author), Josaia Samuela (Author), Mike Kama (Author), Meciusela Tuicakau (Author), Lucia Romani (Author), Margot J Whitfeld (Author), Christopher L King (Author), Gary J Weil (Author), Anneke C Grobler (Author), Leanne J Robinson (Author), John M Kaldor (Author), Andrew C Steer (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lymphatic filariasis has remained endemic in Fiji despite repeated mass drug administration using the well-established and safe combination of diethylcarbamazine and albendazole (DA) since 2002. In certain settings the addition of ivermectin to this combination (IDA) remains a safe strategy and is m...